CureVac shares are trading lower after the company announced the Regional Court Düsseldorf has decided to suspend proceedings on four intellectual property rights in the infringement lawsuit filed by CureVac against BioNTech.
Portfolio Pulse from Benzinga Newsdesk
CureVac's shares are trading lower following the announcement that the Regional Court Düsseldorf has decided to suspend proceedings on four intellectual property rights in the infringement lawsuit filed by CureVac against BioNTech.
September 28, 2023 | 2:36 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CureVac's stock price is trading lower after the court decided to suspend proceedings in its lawsuit against BioNTech.
The suspension of the lawsuit proceedings is seen as a setback for CureVac, which may have led to the decrease in its stock price. The outcome of this lawsuit could have significant implications for the company's intellectual property rights and its competitive position in the market.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100